NO331205B1 - Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav - Google Patents

Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav

Info

Publication number
NO331205B1
NO331205B1 NO20055016A NO20055016A NO331205B1 NO 331205 B1 NO331205 B1 NO 331205B1 NO 20055016 A NO20055016 A NO 20055016A NO 20055016 A NO20055016 A NO 20055016A NO 331205 B1 NO331205 B1 NO 331205B1
Authority
NO
Norway
Prior art keywords
solid dosage
pharmaceutical composition
dosage form
desmopressin
preparation
Prior art date
Application number
NO20055016A
Other languages
English (en)
Other versions
NO20055016L (no
Inventor
Lars-Erik Olsson
Hakan Lomryd
Helena Nicklasson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32981781&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO331205(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20055016L publication Critical patent/NO20055016L/no
Publication of NO331205B1 publication Critical patent/NO331205B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

Foreliggende oppfinnelse vedrører en ny farmasøytisk sammensetning som en fast doseringsform omfattende desmopressin som en terapeutisk aktiv ingrediens og en fremgangsmåte for fremstilling derav. Oppfinnelsen vedrører en farmasøytisk sammensetning som en fast doseringsform omfattende desmopressin, eller et farmasøytisk akseptabelt salt derav, som en terapeutisk aktiv ingrediens sammen med en farmasøytisk akseptabel eksipiens, fortynner eller bærer, eller blanding derav, hvori minst en av eksipiensen, fortynneren og bæreren er en substans valgt fra et monosakkarid, disakkarid, oligosakkarid og et polysakkarid, hvori substansen har en gjennomsnittlig partikkelstørrelse i området fra 60 til 1 000 pm. En fremgangsmåte ifølge foreliggende oppfinnelse gir en forbedret produksjon av faste doseringsformer av desmopressin.
NO20055016A 2003-04-30 2005-10-27 Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav NO331205B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03009659A EP1473029B1 (en) 2003-04-30 2003-04-30 Solid dosage form comprising desmopressin
PCT/EP2004/004597 WO2004096181A2 (en) 2003-04-30 2004-04-30 Solid dosage form comprising desmopressin

Publications (2)

Publication Number Publication Date
NO20055016L NO20055016L (no) 2005-10-27
NO331205B1 true NO331205B1 (no) 2011-10-31

Family

ID=32981781

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055016A NO331205B1 (no) 2003-04-30 2005-10-27 Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav

Country Status (18)

Country Link
EP (2) EP1473029B1 (no)
JP (1) JP4597124B2 (no)
KR (1) KR100766455B1 (no)
CN (1) CN100438857C (no)
AT (1) ATE291419T1 (no)
AU (1) AU2004233596B2 (no)
CA (1) CA2486833C (no)
DE (1) DE60300414T2 (no)
DK (1) DK1473029T3 (no)
ES (1) ES2236640T3 (no)
MX (1) MXPA05011591A (no)
NO (1) NO331205B1 (no)
NZ (1) NZ542653A (no)
PL (1) PL211799B1 (no)
PT (1) PT1473029E (no)
RU (1) RU2290945C2 (no)
SI (1) SI1473029T1 (no)
WO (1) WO2004096181A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7022340B2 (en) * 2003-07-25 2006-04-04 Ferring B.V. Pharmaceutical composition as solid dosage form and method for manufacturing thereof
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
CN102423485B (zh) * 2011-12-08 2014-08-06 赵联华 含有醋酸去氨加压素的口服组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8306367L (sv) * 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
US6210699B1 (en) * 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
JP2001139461A (ja) * 1999-11-10 2001-05-22 Ohta Pharmaceut Co Ltd 速崩壊性錠剤
JP4596586B2 (ja) * 2000-01-27 2010-12-08 旭化成ケミカルズ株式会社 トレハロース粒子
ATE482692T1 (de) * 2001-07-27 2010-10-15 Astellas Pharma Inc Zusammensetzung enthaltend feine körner mit verzögerter freisetzung für in der mundhöhle schnell zerfallende tabletten

Also Published As

Publication number Publication date
DE60300414T2 (de) 2006-05-11
NZ542653A (en) 2008-04-30
CN100438857C (zh) 2008-12-03
PT1473029E (pt) 2005-05-31
SI1473029T1 (en) 2005-10-31
PL211799B1 (pl) 2012-06-29
DE60300414D1 (de) 2005-04-28
CA2486833A1 (en) 2004-11-11
WO2004096181A3 (en) 2004-12-23
EP1473029A1 (en) 2004-11-03
NO20055016L (no) 2005-10-27
DK1473029T3 (da) 2005-04-18
MXPA05011591A (es) 2005-12-15
KR20060012592A (ko) 2006-02-08
JP2006524663A (ja) 2006-11-02
RU2290945C2 (ru) 2007-01-10
ATE291419T1 (de) 2005-04-15
EP1670439A2 (en) 2006-06-21
AU2004233596B2 (en) 2010-04-08
CN1780608A (zh) 2006-05-31
CA2486833C (en) 2005-08-02
ES2236640T3 (es) 2005-07-16
RU2005131494A (ru) 2006-03-20
KR100766455B1 (ko) 2007-10-15
WO2004096181A2 (en) 2004-11-11
PL379703A1 (pl) 2006-11-13
JP4597124B2 (ja) 2010-12-15
AU2004233596A1 (en) 2004-11-11
EP1473029B1 (en) 2005-03-23

Similar Documents

Publication Publication Date Title
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
NO20051896L (no) Farmasoytisk sammensetning som fast doseringsform samt fremgangsmate for fremstilling derav
SG146608A1 (en) Rapid dissolution formulation of a calcium receptor-active compound
EA201190012A1 (ru) Твердые лекарственные формы бендамустина
EA200401583A1 (ru) Таблетка лазофоксифена и ее покрытие
WO2004078105A3 (fr) Composition de fondaparinux sodique de haute purete
CA2445519A1 (en) Method for manufacturing a low dose pharmaceutical composition
WO2004096823A3 (en) Novel ketolide derivatives
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
NO20055016L (no) Farmasoytisk sammensetning som fast doseringsform og fremgangsmate for fremstilling derav
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
WO2004096822A3 (en) Pyridyl substituted ketolide antibiotics
BR0203517A (pt) Composição farmacêutica estéril aquosa, e, método para preparar uma composição farmacêutica estéril aquosa
ATE441410T1 (de) Fenofibrattabletten
YU72802A (sh) Farmaceutske smeše koje sadrže oligosaharide, novi oligosaharidi i njihovo dobijanje
WO2007044574A3 (en) Pharmaceutical compositions, methods of preparation thereof, and methods of treatment
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
WO2005020876A3 (en) Pharmaceutical composition, method of manufacturing and therapeutic use thereof
WO2004000864A3 (en) 11-c-substituted ketolides